Cationic Liposomes Containing Mycobacterial Lipids: a New Powerful Th1 Adjuvant System
Tóm tắt
Từ khóa
Tài liệu tham khảo
Dobson, G., D. E. Minnikin, S. M. Minnikin, J. H. Parlett, M. Goodfellow, M. Ridell, and M. Magnusson. 1985. Systematic analysis of complex mycobacterial lipids, p. 237-265. In M. Goodfellow and D. E. Minnikin (ed.), Chemical methods in bacterial systematics, vol. 1. Academic Press, London, United Kingdom.
European Medicines Agency. 2004. Guideline on adjuvants in vaccines for human use. European Medicines Agency London United Kingdom. [Online.] http://www.emea.eu.int/pdfs/human/veg/001703en.pdf .
Freund, J. 1956. The mode of action of immunologic adjuvants, p. 130-148. In H. Birkhäuser, Advances in tuberculosis research. Karger, Basel, Switzerland.
Higuchi, S., M. Suga, A. M. Dannenberg, Jr., L. F. Affronti, I. Azuma, T. M. Daniel, and J. P. Petrali. 1981. Persistence of protein, carbohydrate and wax components of tubercle bacilli in dermal BCG lesions. Am. Rev. Respir. Dis.123:397-401.
Suzuki, F., R. R. Brutkiewicz, and R. B. Pollard. 1986. Importance of Lyt 1+ T-cells in the antitumor activity of an immunomodulator, SSM, extracted from human-type Tubercle bacilli. J. Natl. Cancer Inst.77:441-447.
Veronesi, R., A. Correa, and D. Alterio. 1970. Single dose immunization against tetanus. Promising results in human trials. Rev. Inst. Med. Trop. Sao Paulo12:46-54.